Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIAN HEALTHCARE vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CIAN HEALTHCARE   ACTAVIS
EQUITY SHARE DATA
    CIAN HEALTHCARE
Mar-23
ACTAVIS
Dec-18
CIAN HEALTHCARE/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs3216,126-   
Low Rs1210,818-   
Sales per share (Unadj.) Rs27.43,955.8-  
Earnings per share (Unadj.) Rs0.8-1,274.2-  
Cash flow per share (Unadj.) Rs3.0416.9-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs23.016,315.7-  
Shares outstanding (eoy) m25.00332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.83.4 23.5%   
Avg P/E ratio x27.0-10.6 -255.6%  
P/CF ratio (eoy) x7.432.3 22.7%  
Price / Book Value ratio x1.00.8 115.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m5494,480,758 0.0%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m890-   
Avg. sales/employee Rs Th077,851.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,076.0-  
INCOME DATA
Net Sales Rs m6861,315,689 0.1%  
Other income Rs m625,160 0.0%   
Total revenues Rs m6921,340,849 0.1%   
Gross profit Rs m13134,478 0.4%  
Depreciation Rs m54562,428 0.0%   
Interest Rs m6375,923 0.1%   
Profit before tax Rs m20-578,713 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,595 0.0%   
Tax Rs m0-7,334 0.0%   
Profit after tax Rs m20-423,784 -0.0%  
Gross profit margin %19.12.6 728.9%  
Effective tax rate %-1.91.3 -153.4%   
Net profit margin %3.0-32.2 -9.2%  
BALANCE SHEET DATA
Current assets Rs m742539,627 0.1%   
Current liabilities Rs m653477,372 0.1%   
Net working cap to sales %13.14.7 276.6%  
Current ratio x1.11.1 100.6%  
Inventory Days Days9420 481.3%  
Debtors Days Days1,39666 2,105.1%  
Net fixed assets Rs m762148,929 0.5%   
Share capital Rs m2500-   
"Free" reserves Rs m3250-   
Net worth Rs m5755,426,601 0.0%   
Long term debt Rs m2941,910,903 0.0%   
Total assets Rs m1,6058,483,012 0.0%  
Interest coverage x1.3-6.6 -19.9%   
Debt to equity ratio x0.50.4 145.2%  
Sales to assets ratio x0.40.2 275.6%   
Return on assets %5.2-4.1 -126.5%  
Return on equity %3.5-7.8 -45.2%  
Return on capital %9.5-4.8 -197.1%  
Exports to sales %13.70-   
Imports to sales %00-   
Net fx Rs m940-   
CASH FLOW
From Operations Rs m48470,046 0.0%  
From Investments Rs m26258,229 0.0%  
From Financial Activity Rs m-74-806,740 0.0%  
Net Cashflow Rs m0-78,073 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare CIAN HEALTHCARE With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare CIAN HEALTHCARE With: FABINO LIFE   BACIL PHARMA  VINEET LABORATORIES  DECIPHER LABS  IND. SWIFT  



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.